Mathilde Merlet's lobbying: the registrations they file and every meeting they've reported since November 2021.
← Lobbying
Registrant (responsible officer)
Mathilde Merlet
President and General Manager
For companies and organizations, the most senior paid officer files the registration and the monthly reports, whoever attended the meeting.
Meetings this Parliament
21
Since Nov 2021
21
Active registrations
1
Dec 2024 Reports per month Nov 2026
Reported meetings
Eric Costen · Deputy Secretary to the Cabinet (Operations), Privy Council Office (PCO)
Pharmaceutical pricing policy arising from the jurisdiction of the Patented Medicines Prices Review Board (PMPRB)
Read more
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
Official report
Paul Moen · Chief of Staff, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Samuel Millar · Assistant Deputy Minister, Finance Canada (FIN)
Omar Rajabali · Director General, Finance Canada (FIN)
Nicholas Chesterley · Director General, Finance Canada (FIN)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Karim Bardeesy · Member of Parliament
Paul Moen · Chief of Staff to the Minister, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Philip Jennings · Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Alexis Conrad · Assistant Secretary to the Cabinet, Economic Regional Development Policy, Privy Council Office (PCO)
Isabelle Mondou · Deputy Clerk of the Privy Council and Associate Secretary to the Cabinet, Privy Council Office (PCO)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Maggie Chi · Member of Parliament
Justine Frame · Policy Advisor, Health Canada (HC)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Nasser Haidar · Senior Policy Advisor, Intergovernmental Affairs Secretariat (IGA)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Dominic LeBlanc · President of the King's Privy Council for Canada and Minister of International Trade and Intergovernmental Affairs
Karim Bardeesy · Member of Parliament
Marjorie Michel · Minister of Health, Health Canada (HC)
Janice Charette · Chief Trade Negotiator, Global Affairs Canada (GAC)
and 7 more Show fewer
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Martin Moen · Associate Assistant Deputy Minister for International Trade, Global Affairs Canada (GAC)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
Nasser Haidar · Senior Policy Advisor, Intergovernmental Affairs Secretariat (IGA)
Sandenga Yeba · Director of Policy & Deputy Chief of Staff, Health Canada (HC)
Justine Frame · Policy Advisor, Health Canada (HC)
Shalene Curtis-Micallef · Deputy Minister, Health Canada (HC)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Martin Moen · Associate Assistant Deputy Minister for International Trade, Global Affairs Canada (GAC)
Loris Mirella · Director, Global Affairs Canada (GAC)
Patrick Blanar · Director, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
and 1 more Show fewer
David Noris · Senior Trade Policy Officer, Global Affairs Canada (GAC)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Miro Froehlich · Director of Policy, Privy Council Office (PCO)
Brandan Rowe · Chief of Staff, Privy Council Office (PCO)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Brandan Rowe · Chief of Staff, Privy Council Office (PCO)
Miro Froehlich · Director of Policy, Privy Council Office (PCO)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Brandan Rowe · Chief of Staff, Intergovernmental Affairs Secretariat (IGA)
Miro Froehlich · Director of Policy, Intergovernmental Affairs Secretariat (IGA)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Senior Director, Innovation, Science and Economic Development Canada (ISED)
Jocelyne Voisin · Senior Assistant Deputy Minister, Health Canada (HC)
Daniel MacDonald · Director General, Health Canada (HC)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Mélanie Joly · Minister of Industry and Minister responsible for Canada Economic Development for Quebec Regions, Innovation, Science and Economic Development Canada (ISED)
Manuela Tomic · Senior Policy Advisor, Innovation, Science and Economic Development Canada (ISED)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Andrea Clements · Sr Trade Commissioner, Global Affairs Canada (GAC)
Kaitlyn Pritchard · Trade Program Manager, Global Affairs Canada (GAC)
Wallace Ip · First Secretary (defence trade policy), Global Affairs Canada (GAC)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Read more
Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
Official report
Matt Strauss · Member of Parliament
Sean Finnigan · Chief of Staff, House of Commons
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Read more
Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
Official report
Ritu Banerjee · Assistant Deputy Minister, Innovation, Science and Economic Development Canada (ISED)
Rodrigo Arancibia · Director, Innovation, Science and Economic Development Canada (ISED)
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Read more
Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
Official report
Daryl Fridhandler · Senator, Senate of Canada
Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
Read more
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Official report
Peter Fragiskatos · Member of Parliament
The government's economic, health, investment, science and technology, and trade policies as they relate to the pharmaceutical industry
Read more
Pharmaceutical and trade policy as it relates to security of supply for Canadian medicines.
Official report
From the Office of the Commissioner of Lobbying's open data , published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence .
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.